NRX Pharmaceuticals, Inc. cotiza a 2.70 USD y tiene una capitalización bursátil de $117M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develop…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.04 | $0.18 |
| Estimado | $-0.15 | $-0.13 | $-0.11 | $-0.08 |
| Sorpresa | — | — | +63.6% | +325.0% |
| Métrica | NRXP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 58.8% | 57.0% | +1.7% |
| Operating Margin | -1324.4% | -38.6% | -1285.8% |
| Net Margin | -2336.5% | -33.6% | -2302.9% |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -220.9% | -32.0% | -188.9% |
| Current Ratio | 0.31 | 2.84 | -2.53 |
| Debt / Equity | — | 0.28 | — |